These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17011169)
1. Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D. Thomas EA; Yao JK Schizophr Res; 2007 Jan; 89(1-3):147-53. PubMed ID: 17011169 [TBL] [Abstract][Full Text] [Related]
2. Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Yao JK; Thomas EA; Reddy RD; Keshavan MS Schizophr Res; 2005 Jan; 72(2-3):259-66. PubMed ID: 15560970 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake. Labrie M; Lalonde S; Najyb O; Thiery M; Daneault C; Des Rosiers C; Rassart E; Mounier C PLoS One; 2015; 10(6):e0130230. PubMed ID: 26083030 [TBL] [Abstract][Full Text] [Related]
4. Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. Thomas EA; Danielson PE; Nelson PA; Pribyl TM; Hilbush BS; Hasel KW; Sutcliffe JG J Neurochem; 2001 Feb; 76(3):789-96. PubMed ID: 11158250 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. Khan MM; Parikh VV; Mahadik SP J Neurochem; 2003 Sep; 86(5):1089-100. PubMed ID: 12911617 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Thomas EA; George RC; Danielson PE; Nelson PA; Warren AJ; Lo D; Sutcliffe JG Mol Psychiatry; 2003 Nov; 8(12):983-93, 950. PubMed ID: 14647396 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Bajo-Grañeras R; Ganfornina MD; Martín-Tejedor E; Sanchez D Glia; 2011 Oct; 59(10):1551-66. PubMed ID: 21688324 [TBL] [Abstract][Full Text] [Related]
8. From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Thomas EA; Copolov DL; Sutcliffe JG Curr Mol Med; 2003 Aug; 3(5):408-18. PubMed ID: 12942994 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Thomas EA; George RC; Sutcliffe JG Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):421-7. PubMed ID: 14623496 [TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism. Do Carmo S; Fournier D; Mounier C; Rassart E Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E802-11. PubMed ID: 19176353 [TBL] [Abstract][Full Text] [Related]
11. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis. Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. Bajo-Grañeras R; Sanchez D; Gutierrez G; González C; Do Carmo S; Rassart E; Ganfornina MD J Neurochem; 2011 Jun; 117(6):949-60. PubMed ID: 21463325 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Dassati S; Waldner A; Schweigreiter R Neurobiol Aging; 2014 Jul; 35(7):1632-42. PubMed ID: 24612673 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis. Desmarais F; Bergeron KF; Rassart E; Mounier C Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Apr; 1864(4):522-531. PubMed ID: 30630053 [TBL] [Abstract][Full Text] [Related]
16. Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. Mahadik SP; Khan MM; Evans DR; Parikh VV Schizophr Res; 2002 Nov; 58(1):55-62. PubMed ID: 12363390 [TBL] [Abstract][Full Text] [Related]
17. Phospholipid sources for adrenic acid mobilization in RAW 264.7 macrophages. Comparison with arachidonic acid. Guijas C; Astudillo AM; Gil-de-Gómez L; Rubio JM; Balboa MA; Balsinde J Biochim Biophys Acta; 2012 Nov; 1821(11):1386-93. PubMed ID: 22824377 [TBL] [Abstract][Full Text] [Related]
18. Aging without Apolipoprotein D: Molecular and cellular modifications in the hippocampus and cortex. Sanchez D; Bajo-Grañeras R; Del Caño-Espinel M; Garcia-Centeno R; Garcia-Mateo N; Pascua-Maestro R; Ganfornina MD Exp Gerontol; 2015 Jul; 67():19-47. PubMed ID: 25868396 [TBL] [Abstract][Full Text] [Related]
19. Studies of ApoD El-Darzi N; Mast N; Petrov AM; Dao T; Astafev AA; Saadane A; Prendergast E; Schwarz E; Bederman I; Pikuleva IA Cell Mol Life Sci; 2021 Feb; 78(3):963-983. PubMed ID: 32440710 [TBL] [Abstract][Full Text] [Related]
20. Dietary conjugated linoleic acid alters long chain polyunsaturated fatty acid metabolism in brain and liver of neonatal pigs. Lin X; Bo J; Oliver SA; Corl BA; Jacobi SK; Oliver WT; Harrell RJ; Odle J J Nutr Biochem; 2011 Nov; 22(11):1047-54. PubMed ID: 21216581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]